Brind.

Fortress Biotech established partnerships with AstraZeneca and Fred Hutchinson Cancer Center.

2 reports, 2 independent Updated Sep 2

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Fortress Biotech established partnerships with AstraZeneca and Fred Hutchinson Cancer Center.

Who's involved

What this event is mainly about

Fortress Biotech AstraZeneca Fred Hutchinson Cancer Center

Keep exploring

The entities involved

Fortress Biotech
company
- The financial health and market performance of Fortress Biotech and Theravance Biopharma are currently under direct comparison.Sun 11:50
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.Mon 11:04
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.Sat 18:52
Fred Hutchinson Cancer Center
cancer research institute in Seattle, Washington, United States

Nothing else this week.

Related events

Petra Hamerlik, who previously worked at AstraZeneca plc, has been appointed as the Chair of Translational Neuro-Oncology at the University of Manchester.Sep 10

Coverage

Newest first; wire copies grouped

Sep 2GlobeNewswireFortress Biotech to Present at the H.C. Wainwright 27th Annual Global Investment Conference MIAMI, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative
Aug 16Simply Wall St.Fortress Biotech Second Quarter 2025 Earnings: Beats Expectations Explore Fortress Biotech's Fair Values from the Community and select yours Revenue: US$16.4m (up 10% from 2Q 2024). Net income: US$1